Table 1.
Variable | N | Mean | SD |
---|---|---|---|
Age (years) | 72 | 65.75 | 1.10 |
BMI (kg/m2) | 72 | 26.19 | 0.54 |
Illness duration (years) | 72 | 13.90 | 1.09 |
Body composition and muscle strength | |||
Fat percentage (%) | 72 | 36.50 | 1.03 |
Fat mass (kg) | 72 | 27.23 | 1.24 |
Visceral fat level | 72 | 9.68 | 0.33 |
Metabolic age (years) | 72 | 64.68 | 1.48 |
Fat free mass (kg) | 72 | 45.16 | 0.79 |
Total body water (%) | 72 | 31.47 | 0.64 |
Muscle mass (kg) | 72 | 42.87 | 0.75 |
Bone mass (kg) | 72 | 2.30 | 0.04 |
Basal metabolic rate (cal/day) | 72 | 5705.6 | 97.5 |
Daily calorie intake (kJ) | 72 | 9420 | 176 |
Muscle strength—men (kg) | 6 | 19.17 | 1.22 |
Muscle strength—women (kg) | 66 | 13.95 | 1.44 |
Disease specific parameters | |||
DAS tender joint | 72 | 11.44 | 0.75 |
DAS swollen joint | 72 | 7.86 | 0.49 |
DAS ESR (mm/hr) | 72 | 28.60 | 2.53 |
DAS VAS | 72 | 50.35 | 2.01 |
DAS result | 72 | 5.40 | 0.14 |
HAQ-DI | 71 | 1.19 | 0.52 |
NRS | 71 | 0.33 | 0.10 |
Medication | |||
NSAID | 46 | ||
CSDMARD | 62 | ||
BDMARD | 6 | ||
Paracetamol | 4 | ||
Paracetamol/Tramadol | 22 | ||
Corticosteroids | 55 | ||
Number of medications | |||
≤3 | 20 | ||
>3 | 50 | ||
Comorbidities | |||
Arterial hypertension | 46 | ||
Diabetes mellitus | 8 | ||
Chronic kidney disease | 1 | ||
Hyperlipidemia | 11 | ||
Coronary artery disease | 11 | ||
Gastric ulcer | 23 | ||
Thyroid disease | 15 | ||
Mineral bone density | |||
Osteopenia | 23 | ||
Osteoporosis | 36 | ||
Lifestyle | |||
Education level | |||
Elementary school | 32 | ||
High school | 36 | ||
Bachelor’s/Master’s | 4 | ||
Martial status | |||
Married/Widowed | 38 | ||
Unmarried | 34 | ||
Exercise | 34 | ||
N. of weekly exercises | |||
2 | 7 | ||
3 | 9 | ||
4 | 5 | ||
5 | 6 | ||
6 | 4 | ||
7 | 3 |
Abbreviations: N—number, SD—standard deviation, BMI—body mass index (kg/m2), DAS—disease activity score, DAS ESR—disease activity score erythrocyte sedimentation rate, DAS VAS—disease activity score visually analogue scale, NRS—nutrition risk screening score, HAQ-DI—health assessment questionnaire-disability index, NSAID—non-steroid anti-inflammatory drug, CSDMARD—conventional synthetic disease-modifying antirheumatic drugs, BDMARD—biologic disease-modifying antirheumatic drugs.